Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Last Updated: August 14, 2022

Details for Patent: 6,770,295

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Summary for Patent: 6,770,295
Title: Therapeutic formulation for administering tolterodine with controlled release
Abstract:The present invention is drawn to a method of treating an unstable or overactive urinary bladder by treating the patient with tolterodine or a tolterodine-related compound, or pharmaceutically acceptable salt thereof, with a controlled release formulation that maintains a substantially constant serum level of the active moiety or moieties for at least 24 hours. The present invention is further drawn to a formulation for the method.
Inventor(s): Kreilg.ang.rd; Bo (Hillerod, DK), Orup Jacobsen; Lene (Gentofte, DK), Hoeck; Ulla (Hillerod, DK), Kristensen; Helle (Slangerup, DK), Gren; Torkel (Uppsala, SE), Nilvebrant; Lisbeth (Bromma, SE), Ringberg; Anders (Stockholm, SE), Wikberg; Martin (Kullavik, SE), Hallen; Bengt (Sollentuna, SE), Olsson; Birgitta (Stenhamra, SE), Strombom; Jan (Vattholma, SE)
Assignee: Pharmacia AB (Stockholm, SE)
Application Number:09/582,498
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,770,295
Patent Claim Types:
see list of patent claims
Use; Formulation; Dosage form; Delivery; Compound;

Drugs Protected by US Patent 6,770,295

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,770,295

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden9802864Aug 27, 1998
Sweden9803871Nov 11, 1998
PCT Information
PCT FiledAugust 26, 1999PCT Application Number:PCT/SE99/01463
PCT Publication Date:March 09, 2000PCT Publication Number: WO00/12069

International Family Members for US Patent 6,770,295

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 1323 See Plans and Pricing
African Regional IP Organization (ARIPO) 1529 See Plans and Pricing
Argentina 027815 See Plans and Pricing
Argentina 029311 See Plans and Pricing
Austria 247458 See Plans and Pricing
Austria 300941 See Plans and Pricing
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.